respiratori
tract
cell
structur
function
differ
upper
respiratori
tract
nasal
sinusoid
epithelia
conduct
airway
tracheal
bronchial
epithelia
alveoli
alveolar
epithelia
natur
target
cell
respiratori
viru
infect
primari
human
respiratori
epitheli
cell
cultur
provid
ideal
vitro
system
investig
cell
factor
requir
growth
respiratori
human
virus
analysi
interact
virus
innat
immun
respons
infect
isol
propag
novel
respiratori
pathogen
alveolar
epithelium
consist
alveolar
type
cell
ati
make
surfac
area
lung
termin
differenti
nondivid
function
ga
exchang
fluid
homeostasi
alveolar
type
ii
cell
atii
produc
surfact
protein
lipid
divid
differenti
replac
damag
ati
cell
particip
fluid
homeostasi
contribut
innat
defens
lung
laboratori
develop
system
isol
cultur
primari
atii
cell
human
lung
special
cultur
condit
transdifferenti
atii
cell
atilik
phenotyp
fifth
human
coronaviru
discov
rtpcr
screen
conserv
coronaviru
primer
respiratori
sampl
adult
patient
pneumonia
neg
sever
acut
respiratori
syndrom
coronaviru
sarscov
date
associ
upper
lower
respiratori
tract
ill
children
adult
recent
research
limit
could
isol
clinic
specimen
continu
cell
line
vitro
report
infect
anim
use
primari
human
ciliat
airway
epitheli
cell
cultur
pyrc
et
al
isol
propag
recent
dijkman
et
al
extend
observ
addit
primari
isol
similarli
develop
primari
human
bronchialtrach
epitheli
cell
htbec
cultur
system
airliquid
interfac
ali
success
propag
patient
specimen
parallel
advanc
altern
approach
studi
reason
like
sarscov
may
abl
infect
serial
propag
human
alveolar
cell
sinc
viru
known
caus
pneumonia
subset
patient
furthermor
reason
infect
primari
human
alveolar
cell
would
allow
us
determin
subset
cell
suscept
infect
character
initi
innat
immun
respons
alveolar
epitheli
cell
virus
caus
lower
respiratori
tract
diseas
demonstr
infect
serial
propag
primari
human
alveolar
type
ii
cell
alveolar
type
ilik
cell
alveolar
macrophag
airliquid
interfac
human
alveolar
macrophag
alveolar
cell
isol
previous
describ
briefli
deidentifi
donor
lung
suitabl
transplant
obtain
nation
diseas
research
interchang
philadelphia
pa
intern
institut
advanc
medicin
edison
nj
isol
cell
conduct
previous
describ
except
type
ii
cell
posit
select
use
epcam
magnet
bead
miltenyi
auburn
ca
cell
plate
dmem
fb
millicel
insert
millipor
bedford
coat
mixtur
rat
tail
collagen
matrigel
bd
bioscienc
san
jose
ca
cell
allow
adher
insert
day
submerg
dmem
fb
cultur
airliquid
interfac
dmem
charcoalstrip
serum
csfb
supplement
keratinocyt
growth
factor
k
day
switch
media
addit
isobutylmethylxanthin
dexamethason
day
achiev
atii
differenti
phenotyp
prior
infect
day
plate
alveolar
macrophag
alveolar
type
ilik
cell
cultur
character
report
previous
briefli
transdifferenti
type
ii
cell
type
cell
type
ii
cell
plate
rat
tail
dish
densiti
dmem
fb
h
medium
chang
fb
without
addit
type
ilik
cell
phenotyp
document
posit
stain
receptor
advanc
glycat
end
product
rage
r
system
minneapoli
mn
epitheli
membran
protein
sigmaaldrich
inc
stloui
mo
alveolar
macrophag
middl
lobe
lung
perfus
lavag
hepesbuff
salin
contain
mm
edta
hepesbuff
salin
alon
macrophag
puriti
adher
cell
nearli
demonstr
stain
cd
dakocytom
carpinteria
ca
puriti
type
ii
cell
demonstr
figur
level
surfact
protein
express
publish
clinic
nasopharyng
specimen
contain
rna
identifi
pediatr
patient
respiratori
symptom
submit
test
clinic
virolog
laboratori
children
hospit
colorado
xtag
respiratori
viru
panel
rvp
luminex
molecular
diagnost
toronto
cn
aliquot
sampl
posit
rna
store
viral
transport
media
remel
laboratori
lenexa
ks
isol
five
differ
patient
use
studi
cell
inocul
primari
clinic
isol
isol
passag
one
time
primari
differenti
human
bronchialtrach
epitheli
cell
htbec
viru
lifelin
cell
technolog
walkersvil
md
dilut
dmem
bovin
serum
albumin
bsa
hour
incub
inoculum
remov
cell
incub
cell
kept
airliquid
interfac
ali
apic
surfac
cell
wash
everi
hour
dmem
bsa
collect
pcr
analysi
cell
kept
immers
media
collect
replac
everi
hour
cell
morpholog
monitor
daili
observ
cytopath
effect
three
day
inocul
cell
fix
methanol
viral
antigen
cell
marker
detect
use
immunostain
detect
infect
cell
use
rabbit
polyclon
antibodi
mousemonoclon
antibodi
direct
viral
spike
glycoprotein
develop
laboratori
visual
use
goat
antirabbit
goat
antimous
antibodi
conjug
alexa
fluorophor
life
technolog
grand
island
ny
cell
also
stain
cell
type
specif
marker
atii
cell
spa
gift
yoshio
kuroki
univers
sapporo
japan
prospb
millipor
billerica
leica
biosystem
buffalo
grove
il
mous
igm
antidobb
gift
leland
dobb
univers
california
san
francisco
basal
cell
thermo
scientif
pittsburgh
pa
alveolar
macrophag
clone
dako
inc
carpenteria
ca
immunostain
cell
imag
use
zeiss
axioskop
fluoresc
microscop
axiovis
softwar
zeiss
lsm
laser
scan
confoc
microscop
zen
softwar
nation
jewish
cytometri
core
viral
rna
pool
apic
wash
extract
use
qiagen
viru
mini
kit
valencia
ca
biorobot
extractor
qiagen
valencia
ca
follow
manufactur
instruct
viru
yield
determin
quantit
real
time
rtpcr
qrtpcr
target
polymeras
gene
comparison
copi
number
plasmid
encod
region
recogn
assay
rtpcr
perform
use
reversetranscript
pcr
master
mix
rna
ultrasens
onestep
quantit
rtpcr
system
invitrogen
life
technolog
carlsbad
ca
reaction
mixtur
prepar
use
final
concentr
forward
primer
nm
revers
primer
nm
probe
minor
groov
binder
nonfluoresc
ul
rna
ad
ul
master
mix
contain
addit
mm
mgcl
rtpcr
perform
use
follow
cycl
condit
minut
minut
cycl
second
second
hour
postinfect
cell
harvest
rna
analysi
use
rneasi
rna
extract
kit
qiagen
valencia
ca
cdna
synthesi
use
qscript
cdna
supermix
quanta
bioscienc
gaithersburg
md
quantit
mrna
encod
interferon
cytokin
chemokin
use
taqman
gene
express
assay
appli
biosystem
life
technolog
grand
island
ny
realtim
pcr
primer
probe
rant
cyb
primer
probe
synthes
hous
forward
primer
revers
primer
probe
atctcctagcctgtgcctctgggactgt
forward
primer
revers
primer
probe
forward
primer
revers
primer
probe
ul
reaction
mixtur
prepar
use
ul
cdna
final
probe
concentr
nm
primer
concentr
nm
realtim
pcr
analysi
perform
biorad
instrument
biorad
laboratori
hercul
ca
use
follow
cycl
condit
minut
minut
cycl
second
minut
statist
analysi
perform
use
prism
softwar
graphpad
softwar
inc
la
jolla
ca
gene
express
valu
normal
show
express
rel
cyclophilin
b
cyb
housekeep
gene
committe
protect
human
subject
nation
jewish
health
deem
use
human
lung
donor
cell
nonhuman
subject
research
sinc
risk
donor
donor
deidentifi
use
bank
viru
specimen
clinic
data
research
approv
colorado
multipl
institut
review
board
clinic
isol
denver
co
util
studi
part
larger
set
sampl
collect
part
studi
epidemiolog
cov
infect
pediatr
patient
detail
elsewher
clinic
detail
patient
isol
obtain
summar
tabl
isol
genotyp
determin
subset
primari
human
alveolar
cell
suscept
infect
human
alveolar
type
ilik
cell
alveolar
type
ii
cell
alveolar
macrophag
test
addit
two
differ
condit
cell
growth
compar
submerg
cultur
versu
cultur
airliquid
interfac
ali
cultur
inocul
primari
clinic
isol
passag
viru
titer
viral
rna
wash
apic
surfac
cell
determin
qrtpcr
indic
time
point
cultur
fix
immunolabel
antibodi
spike
glycoprotein
identifi
infect
cell
neither
submerg
airliquid
interfac
type
cell
alveolar
macrophag
suscept
infect
figur
submerg
cultur
type
ii
cell
cell
infect
contrast
type
ii
cell
maintain
airliquid
interfac
support
infect
although
level
infect
vari
individu
subject
type
ii
cell
infect
show
format
larg
syncytia
indic
cell
cell
spread
may
major
factor
viru
spread
within
lung
respiratori
syncyti
viru
parainfluenza
virus
figur
pattern
suscept
atii
cell
ali
infect
reproduc
human
donor
sinc
cultur
differ
donor
test
suscept
infect
although
cell
differ
donor
demonstr
signific
variat
percent
infect
cell
similarli
clinic
specimen
abl
infect
type
ii
cell
airliquid
interfac
atii
cell
morpholog
appear
cobbleston
epitheli
monolay
typic
type
ii
cell
cell
fluoresc
label
antibodi
surfact
protein
spa
prosurfact
protein
b
prospb
thyroid
transcript
type
ii
specif
transmembran
protein
use
antibodi
obtain
dr
leland
dobb
univers
california
san
francisco
figur
clump
airway
basal
cell
cultur
cell
stain
keratin
infect
format
larg
syncytia
cytopath
effect
cpe
detect
type
ii
cell
cultur
ali
examin
kinet
replic
type
ii
alveolar
cell
primari
clinic
specimen
contain
rna
use
inocul
apic
surfac
type
ii
alveolar
cell
hr
return
ali
apic
surfac
wash
hr
post
inocul
assay
rna
qrtpcr
viral
genom
copi
increas
approxim
fold
cours
infect
indic
product
infect
replic
figur
determin
human
alveolar
cell
could
util
propag
apic
surfac
inocul
incub
hr
clinic
sampl
remov
apic
surfac
wash
everi
hr
next
day
serial
passag
infect
perform
inocul
cultur
day
hr
post
inocul
apic
wash
previou
passag
viral
genom
copi
number
maintain
cours
three
passag
figur
immunofluoresc
assay
ifa
antibodi
spike
glycoprotein
perform
hour
confirm
presenc
infect
cell
end
passag
experi
demonstr
genom
copi
detect
apic
wash
infecti
repres
defect
particl
confirm
truli
replic
type
ii
alveolar
cell
ali
alveolar
type
ii
cell
airliquid
interfac
highli
suscept
infect
could
measur
chang
level
express
select
gene
innat
immun
system
cell
respons
infect
hour
post
inocul
infect
induc
markedli
increas
level
mrna
encod
type
iii
interferon
interferonrespons
gene
proinflammatori
chemokin
signific
increas
type
interferon
report
express
alveolar
type
ii
cell
figur
level
rel
cellular
gene
express
vari
significantli
human
donor
test
figur
thu
human
alveolar
type
ii
cell
induc
signific
innat
antivir
respons
infect
extent
respons
vari
differ
human
differ
level
infect
first
studi
demonstr
infect
primari
human
alveolar
type
ii
cell
ali
primari
clinic
specimen
contain
rna
human
alveolar
type
ii
cell
maintain
airliquid
interfac
highli
suscept
infect
alveolar
macrophag
type
ilik
cell
suscept
support
hypothesi
primari
human
alveolar
cell
suitabl
cultur
system
isol
propag
novel
human
respiratori
virus
caus
lower
respiratori
tract
diseas
display
stringent
degre
cell
tissu
host
specif
util
cultur
system
appeal
close
repres
vivo
physiolog
condit
lung
type
ii
cultur
system
allow
identif
termin
human
respiratori
epitheli
cell
suscept
infect
might
provid
insight
spread
infect
conduct
airway
requir
develop
pneumonia
acut
respiratori
distress
syndrom
ard
result
agreement
known
sarscov
anoth
betacoronaviru
lineag
b
caus
sever
lower
respiratori
tract
diseas
autopsi
studi
patient
sarscov
demonstr
express
viral
antigen
type
ii
pneumocyt
previou
studi
laboratori
show
vitro
cultur
human
alveolar
type
ii
cell
ali
suscept
infect
sarscov
similarli
recent
studi
use
human
lung
organ
cultur
demonstr
variou
subtyp
human
influenza
virus
vari
pathogen
potenti
preferenti
infect
type
ii
alveolar
cell
minim
infect
alveolar
macrophag
infect
alveolar
type
cell
studi
also
highlight
differ
pathogen
potenti
influenza
virus
attribut
differ
cellular
tropism
infect
cell
rather
capac
virus
product
replic
type
ii
alveolar
cell
overal
studi
emphas
import
atii
cell
pathogenesi
viral
induc
lower
respiratori
tract
diseas
contrast
virus
human
coronaviru
alphacoronaviru
readili
infect
human
alveolar
macrophag
type
ilik
type
ii
alveolar
cell
interestingli
contrast
sarscov
common
caus
upper
respiratori
tract
infect
rare
caus
sever
lower
respiratori
tract
diseas
differ
clinic
present
coronaviru
may
partial
explain
whether
infect
type
ii
alveolar
cell
sever
observ
regard
infect
type
ii
cell
worth
note
grow
infect
cultur
airliquid
interfac
oppos
keep
submerg
greatli
increas
suscept
type
ii
cell
result
ident
previous
describ
sarscov
interestingli
littl
fluid
apic
surfac
alveolar
epithelium
except
diseas
state
therefor
ali
condit
accur
approxim
vivo
condit
type
ii
cell
cours
experi
infect
cell
differ
donor
type
ii
cell
donor
suscept
infect
although
signific
variabl
degre
suscept
donor
one
possibl
explan
differ
might
differenti
level
receptor
express
receptor
current
unknown
abl
explor
hypothesi
elucid
mechan
increas
suscept
ali
condit
variabl
exhibit
donor
might
unravel
import
cellular
determin
infect
induct
syncytia
format
like
indic
direct
cell
cell
spread
viru
undoubtedli
play
import
role
pathogenesi
lung
diseas
escap
immun
surveil
mani
infect
envelop
virus
directli
move
cell
cell
fusion
adjac
plasma
membran
result
larg
multinucl
giant
cell
abil
confer
multipl
potenti
pathogen
advantag
cell
free
spread
direct
cell
cell
spread
effici
elimin
intrins
barrier
fluidphas
diffus
requir
cell
free
spread
encount
anoth
target
cell
engag
appropri
receptor
movement
infect
cell
also
allow
viru
evad
innat
humor
cellular
defens
viral
fusion
cell
membran
target
cell
viruscel
fusion
essenti
first
step
infect
coronavirus
syncytia
format
also
commonli
seen
coronavirus
play
import
step
viral
pathogenesi
syncytia
format
dendrit
cell
result
cell
death
recent
shown
import
vitro
infect
model
anoth
human
respiratori
coronaviru
syncytia
form
activ
shown
greatli
enhanc
infect
avian
coronaviru
infecti
bronchiti
modul
syncyti
format
help
establish
viral
persist
vitro
cultur
model
infect
murin
coronaviru
mous
hepat
viru
mhv
viruscel
entri
syncytia
format
mediat
coronaviru
spike
protein
class
viral
fusion
protein
major
determin
cell
host
specif
two
import
process
pathogenesi
howev
may
occur
differ
mechan
shown
sarscov
mhv
innat
immun
system
serv
first
line
defens
protect
host
viral
infect
help
shape
result
adapt
immun
respons
characterist
initi
immun
respons
greatli
impact
result
clinic
outcom
express
proinflammatori
cytokin
respons
viral
infect
argu
type
ii
alveolar
cell
target
cell
infect
also
immunecompet
may
directli
influenc
immun
respons
viral
infect
mani
cytokin
respons
human
type
ii
alveolar
cell
ali
induct
similar
previous
describ
influenza
sarscov
one
signific
differ
lack
express
type
interferon
may
reflect
current
assay
conduct
later
time
point
cours
infect
altern
could
due
presenc
uniqu
viral
protein
suppress
ifn
respons
anoth
differ
degre
induct
cytokin
overal
approxim
fold
less
compar
influenza
sarscov
may
import
implic
recent
shown
level
cytokin
respons
type
ii
alveolar
cell
induc
differ
strain
influenza
virus
correl
degre
pathogen
similarli
differ
cytokin
respons
exhibit
differ
human
donor
might
partial
explain
variabl
clinic
outcom
infect
summari
infect
serial
propag
induc
antivir
respons
human
alveolar
type
ii
cell
maintain
airliquid
interfac
type
ii
cell
infect
demonstr
syncytia
format
indic
cell
cell
spread
may
major
factor
viru
spread
vivo
suggest
potenti
mechan
evas
host
immun
surveil
experi
demonstr
strong
tropism
type
ii
alveolar
cell
demonstr
abil
use
human
alveolar
cell
isol
studi
novel
human
respiratori
virus
caus
lower
respiratori
tract
diseas
display
stringent
degre
cell
tissu
host
specif
